Exosomics envisions a world in which a simple blood draw will be sufficient for early diagnosis, easier monitoring and ultimately better patient outcomes. Our mission is to develop and commercialize a new generation of tests for cancer screening and liquid biopsy, based on analysis of circulating extracellular vesicles and exosomes. The company offers a wide range of proprietary solutions for cancer screening and liquid biopsy, suitable for research use and clinical diagnostics.
Exosomics S.p.A. has not received any reviews.
Exosomics S.p.A. has not received any endorsements.